Multi-Drug Resistant Organism (MDRO) / en Sat, 26 Apr 2025 06:15:09 -0500 Fri, 24 Feb 23 15:21:46 -0600 CDC alerts clinicians to increase in drug-resistant Shigellosis infections /news/headline/2023-02-24-cdc-alerts-clinicians-increase-drug-resistant-shigellosis-infections <p>The Centers for Disease Control and Prevention today advised <a href="https://emergency.cdc.gov/han/2023/pdf/CDC_HAN_486.pdf">clinicians</a> to report extensively drug-resistant strains of Shigella infections to their state or local health department, and educate patients and communities at increased risk. About 5% of Shigella infections reported to CDC last year were caused by these strains, up from zero in 2015. Shigella bacteria are easily transmissible and can cause bloody diarrhea that may lead to fever and abdominal cramping.  <br />  </p> Fri, 24 Feb 2023 15:21:46 -0600 Multi-Drug Resistant Organism (MDRO) CDC issues guidance on treating drug-resistant typhoid fever /news/headline/2021-02-16-cdc-issues-guidance-treating-drug-resistant-typhoid-fever <p class="MsoNoSpacing"><span><span>The Centers for Disease Control and Prevention Friday released <a href="https://emergency.cdc.gov/han/2021/han00439.asp">recommendations</a> for treating Extensively Drug-Resistant <i>Salmonella </i>Typhi, a systemic illness transmitted through contaminated food and water and person-to-person contact. </span></span></p> <p class="MsoNoSpacing"><span><span>Following a large outbreak in Pakistan in 2016, CDC has received at least 71 reports of XDR Typhi infection in the United States, including at least nine cases since November 2019 in patients who had not traveled internationally. XDR Typhi strains are resistant to antibiotics generally recommended to treat typhoid fever, including ampicillin, ceftriaxone, chloramphenicol, ciprofloxacin and trimethoprim-sulfamethoxazole. </span></span></p> <p><span><span><span>“Clinicians should consider empiric treatment with a carbapenem, azithromycin, or both agents for suspected typhoid fever in patients who did not travel out of the United States and for those who traveled to Pakistan or Iraq,” CDC said. “Ceftriaxone remains an appropriate empiric treatment option for patients who traveled to countries other than Pakistan and Iraq. Clinicians should adjust treatment based on results of susceptibility testing.”</span></span></span></p> Tue, 16 Feb 2021 16:11:50 -0600 Multi-Drug Resistant Organism (MDRO) Getting Hospitals to Zero | Center /center/strive Tue, 20 Oct 2020 15:40:57 -0500 Multi-Drug Resistant Organism (MDRO)